drug

deutetrabenazine

1 story · latest Jul 29, 2026

Status: FDA approved Apr 2017 · NDA208082, NDA209885, NDA216354
Brands: Austedo, Austedo Xr

Relationships

Developed by Teva Pharmaceutical Industries Ltd

Timeline

Teva posts Q2 2026 GAAP loss on Emalex charge, raises innovative brand outlook

Jul 29Quarterly updatedeutetrabenazine fremanezumab-vfrm

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.